Want to see VTGN full AI Analyst Report?
VistaGen Therapeutics (VTGN) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Fasedienol Nasal Spray - Fasedienol Nasal Spray | Social Anxiety Disorder | Phase II | Recruiting | A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder | Jan 29, 2025 | ― |
| Fasedienol Nasal Spray | Social Anxiety Disorder (Sad) | Phase III | Recruiting | Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4) | Sep 24, 2024 | ― |
| Fasedienol Nasal Spray | Social Anxiety Disorder | Phase III | Recruiting | Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3) | Apr 04, 2024 | ― |
| Ph94b | Social Anxiety Disorder | Phase III | Terminated | Open-label Safety Trial of PH94B in Social Anxiety Disorder (SAD) | Aug 26, 2021 | ― |
| Ph94b Nasal Spray | Social Anxiety Disorder | Phase III | Completed | PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge | Feb 10, 2021 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Fasedienol Nasal Spray - Fasedienol Nasal Spray | Phase II | Social Anxiety Disorder | Recruiting | A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder | Jan 29, 2025 | ― |
| Fasedienol Nasal Spray | Phase III | Social Anxiety Disorder (Sad) | Recruiting | Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4) | Sep 24, 2024 | ― |
| Fasedienol Nasal Spray | Phase III | Social Anxiety Disorder | Recruiting | Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3) | Apr 04, 2024 | ― |
| Ph94b | Phase III | Social Anxiety Disorder | Terminated | Open-label Safety Trial of PH94B in Social Anxiety Disorder (SAD) | Aug 26, 2021 | ― |
| Ph94b Nasal Spray | Phase III | Social Anxiety Disorder | Completed | PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge | Feb 10, 2021 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Vistagen Therapeutics Inc. (VTGN) have in its pipeline
VistaGen Therapeutics VTGN is currently developing the following drugs: Fasedienol Nasal Spray - Fasedienol Nasal Spray, Fasedienol Nasal Spray, Ph94b, Ph94b Nasal Spray. These drug candidates are in various stages of clinical development as the company works toward FDA approval.